In-depth Immunological Investigation of COVID-19.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

The COntAGIouS trial (COvid-19 Advanced Genetic and Immunologic Sampling; an in-depth characterization of the dynamic host immune response to coronavirus SARS-CoV-2) proposes a transdisciplinary approach to identify host factors resulting in hyper-susceptibility to SARS-CoV-2 infection, which is urgently needed for directed medical interventions.

Eligibility criteria

Qualifiers

Patients >/= 18 years old AND

Hospitalised with PCR-confirmed and/or CT-confirmed SARS-CoV-2 disease

Disqualifiers

Age < 18 years old

No informed consent

Trial design

Treatments tested in this trial

  • Patient sampling

Treatment groups

100 Participants
are divided into 2 treatment groups